Back to Search

MALLORY EMIG, MD

MD

Neurology Physician

NPI: 1831696236IndividualAccepts Medicare

Specialties, Licenses & Credentials

Neurology PhysicianPrimary

Psychiatry & Neurology — Neurology

Code: 2084N0400X

126380(MT)

CMS Specialties

PrimaryNEUROLOGY

Education

OTHER

Class of 2017

Research & Publications (12)

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
PMID 19410716·Lancet·2009
3-trial
Leukocytoclastic vasculitis and acute renal failure after influenza vaccination in an elderly patient with myelodysplastic syndrome.
PMID 17028456·Onkologie·2006
5-case
Loss of p53 impedes the antileukemic response to BCR-ABL inhibition.
PMID 16651519·Proc Natl Acad Sci U S A·2006
7-preclinical
The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians.
PMID 16307017·Leukemia·2006
4-observational
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
PMID 15920007·Blood·2005
8-other
Fractalkine-upregulated milk-fat globule EGF factor-8 protein in cultured rat microglia.
PMID 15710462·J Neuroimmunol·2005
7-preclinical
Impact of chemoradiotherapy-induced anemia on survival in uniformly staged patients with locally advanced squamous cell carcinoma of the esophagus.
PMID 15585976·Onkologie·2004
4-observational
Severe West Nile virus disease in healthy adults.
PMID 14699464·Clin Infect Dis·2004
8-other
Hyperbaric oxygen (HBO2) in the treatment of Lemierre syndrome.
PMID 12964852·Undersea Hyperb Med·2003
5-case
Adding weekly irinotecan to high-dose 5-fluorouracil and folinic acid (HD-5-FU/FA) after failure for first-line HD-5-FU/FA in advanced colorectal cancer--a phase II study.
PMID 12439333·Anticancer Drugs·2002
3-trial
Detection and quantification of residual disease in chronic myelogenous leukemia.
PMID 10865964·Leukemia·2000
6-review
Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study Group.
PMID 10607685·Blood·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
2475 E BROADWAY ST
HELENA, MT 59601

Locations (2)

Practice Location

2475 E BROADWAY ST, HELENA, MT
(406) 457-4180

Practice Location

1402 S GRAND BLVD # M260, SAINT LOUIS, MO
(314) 977-9870

Quick Facts

NPI
1831696236
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
1
Locations
2
Years in Practice
9
Publications
12

Are you this provider?

Claim Your Profile